Correlation Between Icosavax and Capricor Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Icosavax and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icosavax and Capricor Therapeutics, you can compare the effects of market volatilities on Icosavax and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Capricor Therapeutics.

Diversification Opportunities for Icosavax and Capricor Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Icosavax and Capricor is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Icosavax i.e., Icosavax and Capricor Therapeutics go up and down completely randomly.

Pair Corralation between Icosavax and Capricor Therapeutics

Given the investment horizon of 90 days Icosavax is expected to generate 4.46 times less return on investment than Capricor Therapeutics. In addition to that, Icosavax is 1.0 times more volatile than Capricor Therapeutics. It trades about 0.02 of its total potential returns per unit of risk. Capricor Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest  425.00  in Capricor Therapeutics on October 21, 2024 and sell it today you would earn a total of  945.00  from holding Capricor Therapeutics or generate 222.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy24.6%
ValuesDaily Returns

Icosavax  vs.  Capricor Therapeutics

 Performance 
       Timeline  
Icosavax 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Icosavax has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Icosavax is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Capricor Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Capricor Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Icosavax and Capricor Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Icosavax and Capricor Therapeutics

The main advantage of trading using opposite Icosavax and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.
The idea behind Icosavax and Capricor Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios